Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial
Authors
Keywords
-
Journal
Vaccines
Volume 9, Issue 3, Pages 224
Publisher
MDPI AG
Online
2021-03-05
DOI
10.3390/vaccines9030224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effects of Secretory IgA in the Mucosal Immune System
- (2020) Yue Li et al. Biomed Research International
- Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
- (2020) Feng-Cai Zhu et al. LANCET
- Establishment and Maintenance of Conventional and Circulation-Driven Lung-Resident Memory CD8+ T Cells Following Respiratory Virus Infections
- (2019) Shiki Takamura et al. Frontiers in Immunology
- A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases
- (2018) Emily J Erbelding et al. JOURNAL OF INFECTIOUS DISEASES
- Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
- (2018) A Danielle Iuliano et al. LANCET
- CD8+ Resident Memory T Cells and Viral Infection
- (2018) Xuejie Wu et al. Frontiers in Immunology
- Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre
- (2017) Victoria M. W. Gould et al. Frontiers in Microbiology
- Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15
- (2016) Jill M. Ferdinands et al. CLINICAL INFECTIOUS DISEASES
- Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination
- (2015) Jeffrey C. Kwong et al. VACCINE
- Intranasal Adenovirus-Vectored Vaccine for Induction of Long-Lasting Humoral Immunity-Mediated Broad Protection against Influenza in Mice
- (2014) E. H. Kim et al. JOURNAL OF VIROLOGY
- Cellular immune correlates of protection against symptomatic pandemic influenza
- (2013) Saranya Sridhar et al. NATURE MEDICINE
- Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+T Cells Induced by Different Adenovirus Vectors
- (2012) Wendy G. Tan et al. JOURNAL OF VIROLOGY
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
- (2012) Christopher S. Ambrose et al. VACCINE
- A Single Sublingual Dose of an Adenovirus-Based Vaccine Protects against Lethal Ebola Challenge in Mice and Guinea Pigs
- (2011) Jin Huk Choi et al. MOLECULAR PHARMACEUTICS
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
- (2011) Dan H. Barouch et al. VACCINE
- Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data
- (2010) Sari Pesonen et al. MOLECULAR PHARMACEUTICS
- A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
- (2010) J.E. Ledgerwood et al. VACCINE
- Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence
- (2010) Joon Young Song et al. VACCINE
- The influence of innate and pre-existing immunity on adenovirus therapy
- (2009) Anne K. Zaiss et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
- (2008) Maria A. Croyle et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started